Gennao Bio
Gennao Bio is pioneering the development of targeted nucleic acid therapeutics using its unique, non-viral GMAB platform technology. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$200m (Public information from Dec 2021)
Hopewell New Jersey (HQ)
Authorizing premium user...